Header Logo

Connection

IVAN ROSAS to Quinazolines

Back to Details
This is a "connection" page, showing publications IVAN ROSAS has written about Quinazolines.
IVAN ROSAS
Connection Strength
0.045
Quinazolines
  1. Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis. Am J Respir Crit Care Med. 2022 12 15; 206(12):1463-1479.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.